Rocha and colleagues reported that, in Ret/PTC1-positive thyroid carcinoma cell TPC-1, cAMP markedly inhibits the Raf/ERK cascade, leading to mTOR pathway inhibition [26]. Here, RET is linked to thyroid gland carcinoma.